Recent infections are associated with decreased risk of rheumatoid arthritis: A population-based case-control study

Annals of the Rheumatic Diseases

Volumn 74, Issue 5, 2015, Pages 904-907

  Sandberg, Maria E C ^a,b   Bengtsson, Camilla ^a   Klareskog, Lars ^c   Alfredsson, Lars ^a   Saevarsdottir, Saedis ^a,c   Kvien, Tore K ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTROENTERITIS; GENITAL TRACT INFECTION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATITIS; RESPIRATORY TRACT INFECTION; RHEUMATOID ARTHRITIS; RISK REDUCTION; SINUSITIS; TONSILLITIS; URINARY TRACT INFECTION; ARTHRITIS, RHEUMATOID; CASE CONTROL STUDY; PROTECTION; QUESTIONNAIRE; REPRODUCTIVE TRACT INFECTIONS; RISK FACTOR; STATISTICAL MODEL; URINARY TRACT INFECTIONS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GASTROENTERITIS; HUMANS; INFECTION; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA; PROSTATITIS; PROTECTIVE FACTORS; REPRODUCTIVE TRACT INFECTIONS; RISK FACTORS; SINUSITIS; SURVEYS AND QUESTIONNAIRES; TONSILLITIS; URINARY TRACT INFECTIONS;

EID: 84926673327     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2014-206493     Document Type: Article

References (17)

1. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008;58:3009-19.
2. Bedaiwi MK, Inman RD. Microbiome and probiotics: link to arthritis. Curr Opin Rheumatol 2014;26:410-15.
3. Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol 2014;26:101-7.
4. Gomez A, Luckey D, Yeoman CJ, et al. Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS ONE 2012;7:e36095.
5. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Bengtsson C, Berglund A, Serra ML, et al. Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis. Scand J Rheumatol 2010;39:344-6.
7. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006;54:38-46.
8. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62: 835-41.
9. Bengtsson C, Nordmark B, Klareskog L, et al. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005;64:1588-94.
10. Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 2011;7:569-78.
11. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
12. Laskin MD, Pope JE, Krizova A, et al. Are infections increased in rheumatoid arthritis (RA) prior to diagnosis? Results of a case control study of RA compared to non-inflammatory musculoskeletal disorders. Scand J Rheumatol 2005;34:74-5.
13. Olhagen B. The intestine and rheumatism. Acta Rheumatol Scand 1970;16:177-83.
14. Svartz N. The treatment of rheumatic polyarthritis with acid azo compounds. Rheumatism 1948;4:180-5.
15. O'Dell JR, Haire CE, Palmer W, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997;40:842-8.
16. Ogrendik M. Antibiotics for the treatment of rheumatoid arthritis. Int J Gen Med 2013;7:43-7.
17. Stone M, Fortin PR, Pacheco-Tena C, et al. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol 2003;30:2112-22.